<PAGE> 1
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check one):
[X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR
For the Period Ended: June 30, 1997
[ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q
[ ] Transition Report on Form 20-F [ ] Transition Report on Form NN-SAR
[ ] Transition Report on Form 11-K
For the Transition Period Ended: _____________________________
READ INSTRUCTION (ON THE BACK PAGE) BEFORE PREPARING FORM, PLEASE PRINT OR TYPE.
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
If the notification related to a portion of the filing checked above,
identify the item(s) to which the notification relates: _____________________.
- --------------------------------------------------------------------------------
PART I. REGISTRANT INFORMATION
Full Name of Registrant La Jolla Diagnostics, Inc.
---------------------------------------
Former name if applicable _____________________________________
Address of principal executive office (Street and number)
7777 Fay Avenue, Suite 160
- ---------------------------------------------------------------
City, State and Zip Code La Jolla, CA 92037
--------------------------------------
PART II. RULE 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25, the following
should be completed. (Check where appropriate.)
(a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without reasonable
effort or expense;
(b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or
portion thereof will be filed on or before the fifteenth
[X] calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q,
or portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.
<PAGE> 2
PART III. NARRATIVE
State below in reasonable detail the reasons why form 10-K, 20-F, 11-K, 10-Q,
N-SAR or the transition report or portion thereof, could not be filed within the
prescribed time period.
There has been a delay in determining the proper value of the Company's
Antisera inventory at June 30, 1997. The Company, in conjunction with it's
auditors, is in the process of making a proper valuation. This analysis
should be completed by October 3, 1997.
- --------------------------------------------------------------------------------
PART VI. OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
Don Brucker (619) 454-6790
(Name) (Area Code) (Telephone Number)
- --------------------------------------------------------------------------------
(2) Have all other periodic reports required under Section 13 or 15 (d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) be filed? If the answer is
no, identify report(s)
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof?
[ ] Yes [X] No
If so: Attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
La Jolla Diagnostics, Inc.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date September 26, 1997 By: /s/ Don Brucker
-------------------- ----------------------------------
President/Chief Executive Officer
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
( other than an executive officer), evidence of the representative's authority
to sign on behalf of the registrant shall be filed with the form.
